Q4 2017 Holdings
Filed 2018-02-14 | 49 holdings | $28.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $15.8M | 250,000 | 55.7% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $10.0M | 250,000 | 35.3% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $2.2M | 550,000 | 7.6% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $72.1K | 850,000 | 0.3% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $24.9K | 1,538,000 | 0.1% |
| Immunomedics Inc(IMMU)Call | COM | 452907108 | $21.0K | 1,300,000 | 0.1% |
| Celgene Corp(CELG)Call | COM | 151020104 | $15.7K | 150,000 | 0.1% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $15.1K | 230,000 | 0.1% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $13.8K | 115,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $12.8K | 325,000 | 0.0% |
| Allergan PLCCall | SHS | G0177J108 | $12.3K | 75,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $11.3K | 150,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $11.0K | 225,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $11.0K | 600,000 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $10.6K | 250,000 | 0.0% |
| Avexis Inc | COM | 05366U100 | $9.4K | 85,000 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $9.2K | 150,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $8.5K | 200,000 | 0.0% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $8.3K | 900,000 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $8.0K | 325,000 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $7.5K | 45,750 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $7.2K | 180,000 | 0.0% |
| Sage Therapeutics Inc(SG7)Put | COM | 78667J108 | $7.2K | 43,700 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $6.9K | 150,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $6.8K | 100,000 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $6.4K | 200,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $6.4K | 500,000 | 0.0% |
| Obseva SA | COM | H5861P103 | $6.0K | 617,100 | 0.0% |
| Aimmune Therapeutics Inc(AIMT) | COM | 00900T107 | $6.0K | 158,200 | 0.0% |
| Horizon Pharma PLC | SHS | G4617B105 | $5.8K | 400,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $5.0K | 185,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $4.7K | 50,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $4.7K | 400,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $4.5K | 500,000 | 0.0% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $3.6K | 65,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $3.5K | 21,537 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $3.5K | 150,000 | 0.0% |
| Inotek Pharmaceuticals Corp | COM | 45780V102 | $3.4K | 1,300,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $3.4K | 175,000 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $3.2K | 825,000 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $3.1K | 300,000 | 0.0% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $2.8K | 100,000 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $2.5K | 700,000 | 0.0% |
| Ablynx NV | SPONSORED ADR | 00372Y105 | $2.2K | 90,000 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $2.1K | 500,000 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $2.0K | 65,000 | 0.0% |
| Nabriva Therapeutics PLC | SHS | G63637105 | $1.2K | 200,000 | 0.0% |
| Currencyshs Brit Pound Ster | BRIT POUND STE | 23129S106 | $1.2K | 9,100 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $727 | 25,000 | 0.0% |